Rocket Pharmaceuticals Inc

11 sept. 2026, 22:36 UTC

Rocket Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of declines over the past four sessions and remaining below its 20-day moving average.

8 sept. 2026, 20:07 UTC

Rocket Pharmaceuticals is declining today, pulling back from an early high amid notable session losses. The stock remains above its 20-day moving average.

4 sept. 2026, 22:14 UTC

Rocket Pharmaceuticals Inc shares are lower in after-market hours following a weak session, despite trading above the 20-day moving average.

3 sept. 2026, 20:07 UTC

Rocket Pharmaceuticals Inc shares are declining amid broader market pressure, with no specific news identified. Earlier, the stock pulled back from a session high.

2 sept. 2026, 22:01 UTC

Rocket Pharmaceuticals shares lower in after-market trading, declining since Wednesday's close. This follows a weaker-than-expected job growth report from ADP.

1 sept. 2026, 21:02 UTC

Rocket Pharmaceuticals Inc shares are lower in after-market hours, amid broader economic concerns and rising crude oil prices linked to geopolitical tensions.

31 aug. 2026, 20:03 UTC

Rocket Pharmaceuticals is lower today amid broader market pressures and concerns over inflation and potential Federal Reserve tightening following comments from Warsh at Jackson Hole.

28 aug. 2026, 23:26 UTC

Rocket Pharmaceuticals Inc shares are lower in after-market trading. Broader market expectations for a rate hike may be influencing investor sentiment.

26 aug. 2026, 20:08 UTC

Rocket Pharmaceuticals is lower as biotechnology stocks face significant pressure, influencing its price action despite remaining above the 20-day moving average.

25 aug. 2026, 23:16 UTC

Rocket Pharmaceuticals shares are lower in after-market hours, following unusual trading activity and a broader market decline influenced by falling crude oil prices.

24 aug. 2026, 20:06 UTC

Rocket Pharmaceuticals shares are higher, reflecting broader market gains. The market peaked early, though no specific company news was identified for the price movement.

21 aug. 2026, 19:51 UTC

Rocket Pharmaceuticals Inc is rising during Friday's session, supported by strength in the biotechnology sector. The stock remains above its 20-day moving average.

20 aug. 2026, 20:06 UTC

Rocket Pharmaceuticals Inc is lower today, reflecting broader pressures in the biotechnology sector. The overall market is also trending downwards.

19 aug. 2026, 20:02 UTC

Rocket Pharmaceuticals Inc shares are sharply higher today, reflecting strong momentum amid notable gains in biotechnology stocks and positive sector dynamics.

18 aug. 2026, 19:46 UTC

Rocket Pharmaceuticals shares are lower today, reflecting a decline since Monday. Broader market trends and rising Treasury yields may be influencing investor sentiment.

17 aug. 2026, 23:46 UTC

Rocket Pharmaceuticals Inc shares are higher in after-market trading, reflecting positive performance despite broader market pressures and no specific company news identified.

14 aug. 2026, 22:01 UTC

Rocket Pharmaceuticals Inc is trading lower in after-market hours, with no specific news identified. Broader market concerns may be influencing the decline.

13 aug. 2026, 19:56 UTC

Rocket Pharmaceuticals Inc shares are lower today, continuing a recent downward trend amid rising U.S. unemployment claims, with no specific company news identified.

12 aug. 2026, 19:16 UTC

Rocket Pharmaceuticals Inc shares are lower today, with no specific news driving the decline. Earlier, the stock reached a session high before falling.

11 aug. 2026, 20:02 UTC

Rocket Pharmaceuticals shares are lower after Wedbush cut its price target to $15, reflecting concerns over mixed second-quarter earnings results.

10 aug. 2026, 23:26 UTC

Rocket Pharmaceuticals reported Q2 net income of $123.2 million, with EPS of $1.08, significantly exceeding estimates. Shares traded higher in after-market hours.

8 aug. 2026, 00:01 UTC

Rocket Pharmaceuticals Inc. shares are higher in after-market trading, advancing modestly since Friday's close and remaining above its 20-day moving average.

7 aug. 2026, 23:01 UTC

Rocket Pharmaceuticals Inc. shares have shown little change in after-market trading, remaining within a narrow band since Friday's close.

6 aug. 2026, 23:06 UTC

Rocket Pharmaceuticals Inc is trading higher in after-market hours, remaining above its 20-day moving average amid no specific news to explain the movement.

5 aug. 2026, 20:02 UTC

Rocket Pharmaceuticals is rising Wednesday, driven by a strong Biotechnology sub-sector. The stock remains above its 20-day moving average during the session.

4 aug. 2026, 19:26 UTC

Rocket Pharmaceuticals shares rise as Wedbush maintains Outperform rating with a $16 price target. The company also reported promising safety results in its Phase 2 trial.

3 aug. 2026, 22:01 UTC

Rocket Pharmaceuticals shares are lower in after-market trading despite a positive clinical safety update on its Phase 2 trial for RP-A501.

31 iul. 2026, 22:01 UTC

Rocket Pharmaceuticals shares declined in after-hours trading, continuing a downward trend since Friday's close. The stock remains below its 20-day moving average.

30 iul. 2026, 21:51 UTC

Rocket Pharmaceuticals is lower in after-market hours, reflecting declines in the Biotechnology sub-sector. The stock remains below its 20-day moving average.

29 iul. 2026, 20:52 UTC

Rocket Pharmaceuticals shares are lower in after-market hours amid a broader market decline driven by rising crude oil prices and geopolitical tensions.